Wisconsin Alumni Research Foundation

WARF) is the private, nonprofit patent and licensing organization for the University of Wisconsin–Madison, one of the world’s great research universities. WARF was founded in 1925 and is a pioneer and innovator among university-based technology transfer offices. WARF’s mission is to support, aid and encourage UW–Madison research by protecting its discoveries and licensing them to commercial partners for beneficial use in the real world. It is best known for commercializing groundbreaking vitamin D therapies, the revolutionary anticoagulant Coumadin®, innovative medical imaging and cancer radiation systems, and its patents for human embryonic stem cells.
RA

Ryan Abrams

Investment Director

John Gransee

CFO and COO

AH

Alain Hung

Deputy CIO

EI

Erik Iverson

CEO

Mike Partsch

Chief Venture Officer

LP

Larry Prosser

Director of Finance and Investments

KR

Katie Rice

Venture Associate, WARF Ventures

LT

Lysa Thoeny

Senior Director, Finance

MW

Mike Wagner

Investment Director

33 past transactions

StudyBlue, Inc.

Venture Round in 2015
StudyBlue is a mobile learning platform designed to help students learn the stuff their teachers teach from improving outcomes in and out of the classroom. StudyBlue provides a Digital Backpack for students to store, study, share, compare, and ultimately master course material – working alone or together. Notes with images and audio, cloud storage for notes, personalized practice quizzes, and crowdsourced study guides are among the tools offered.

LÜM

Seed Round in 2020
LÜM is a Madison startup building a streaming music platform and social network that helps up-and-coming artists grow their fan base.

Silatronix, Inc.

Venture Round in 2013
Silatronix develops organosilicon electrolytes for energy storage devices such as ultracapacitors and lithium-ion batteries. The company's technology combines Dr. West's expertise in organosilicon compounds with that of Dr. Hamers in nanostructured electrodes and electronic properties of materials. It was founded in 2007 and headquartered in Wisconsin, United States.

NeuWave Medical

Series A in 2008
NeuWave Medical develops tools that deliver energy to the human body to treat a variety of serious medical conditions. Their company founders are both engineers and physician-scientists which allows determining a clinical need and design solutions that are clinically relevant, effective, and minimally invasive. They strive to make the highest quality devices that are the products of choice for leading physicians and medical centers around the world. The company was founded in 2004 and is headquartered in Madison, Wisconsin.

Madison Vaccines, Inc.

Series A in 2014
Madison Vaccines, Inc., a biopharmaceutical company, develops therapeutic plasmid DNA vaccines. It focuses on bone metastases and prostate cancer. The company is based in United States.

Roche NimbleGen

Series B in 2001
Roche NimbleGen provides products and services to the life science research market. The company offers SeqCap EZ system, a solution-based capture system that enables enrichment of exome in a single test tube; SeqCap EZ library that covers exome designs, gene panels, and custom content designs; and SeqCap EZ reagents to maximize workflow and order different reagent needs. It also provides SeqCap Epi, an enrichment system that includes a set of target enrichment tools for DNA methylation assessment at single-base resolution, as well as offers SeqCap Epi kits and reagents. The company provides a set of preparation and adapter kits for library construction including SignalMap, a software product for browsing of genomic tracks; and NimbleDesign, an online tool that enables users to design SeqCap EZ choice libraries. It offers DNA microarray products and services for CGH, ChIP-chip, DNA methylation, AccuSNP, CGS, instruments, sequence capture arrays, gene expression microarrays, and their associated workflows. The company also provides online technical and instruction support services. Roche NimbleGen was founded in 1999 and is headquartered in Madison, Wisconsin. As of August 8, 2007, Roche NimbleGen operates as a subsidiary of Roche Holding AG.

StudyBlue, Inc.

Venture Round in 2014
StudyBlue is a mobile learning platform designed to help students learn the stuff their teachers teach from improving outcomes in and out of the classroom. StudyBlue provides a Digital Backpack for students to store, study, share, compare, and ultimately master course material – working alone or together. Notes with images and audio, cloud storage for notes, personalized practice quizzes, and crowdsourced study guides are among the tools offered.
Cellular Dynamics International Inc., (CDI) is a developer and manufacturer of fully functioning cells in industrial quantities to precise specifications. CDI's proprietary products include true human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs) and custom iPSCs and iCell products (MyCell Products). CDI's products provide standardized, easy-to-use, cost-effective access to the human cell, the smallest fully functioning operating unit of human biology. Customers use our products, among other purposes, for drug discovery and screening, to test the safety and efficacy of their small molecule and biological drug candidates, for stem cell banking, and in the research and development of cellular therapeutics.

Asto CT LLC

Series B in 2021
Asto CT was founded on the principle of offering safe, high-quality volumetric imaging to improve quality of life for horses and ensure peace of mind for their owners. Their system for standing x-ray computed tomography (CT) is customized to meet the needs of horses in a safe and comfortable environment for the animal. They are pioneering the use of cutting-edge robotics in combination with advanced multi-slice CT to provide state-of-the-art screening and diagnosis. Their first mission is to improve diagnosis and treatment of conditions of the distal limb and diseases of the head and neck in horses.

Madison Vaccines, Inc.

Series A in 2015
Madison Vaccines, Inc., a biopharmaceutical company, develops therapeutic plasmid DNA vaccines. It focuses on bone metastases and prostate cancer. The company is based in United States.

Mithridion

Series A in 2007
Mithridion is a biopharmaceutical company that discovers and develops drugs for central nervous system disorders, with an initial focus on Alzheimer's disease and schizophrenia.

FluGen, Inc.

Venture Round in 2016
FluGen, Inc. develops vaccines that prevents from the diseases caused by influenza viruses. It offers RedeeFlu, a nasal spray vaccine used to protect against influenza and vaccine-loaded intradermal microneedle delivery device. The company was founded in 2007 and is based in Madison, Wisconsin.

OpGen

Series B in 2005
OpGen, Inc is a privately-held company, based in Gaithersburg, MD, and focused on commercializing rapid, high precision solutions for DNA analysis and genomics with the Argus® Whole Genome Mapping System and MapIt® Services. Using the proprietary technologies provided by OpGen, customers in academic, government, biodefense and research labs as well as premier genome centers around the world can view ordered whole genome maps for a wide range of applications including strain typing for early outbreak response, improved sequence assembly of microbial and now large genomes up to 3 Gb and comparative genomics applications. OpGen Community (Linkedin Group) provides an accessible environment to share information, exchange questions and best practices using OpGen’s technologies in a variety of applications.

Holos

Grant in 2015
Holos is an AR/VR education and training platform that gives people the ability to create, organize, and learn in full 3D. Holos is making it easy for both teachers and students to create their own immersive learning experiences so that they can learn by doing, rather than simply reading or listening. It was founded in 2015 and is headquartered in Madison, Wisconsin.

Stuart Therapeutics

Series A in 2021
Stuart Therapeutics is a biotechnology company that offers PolyCol, a therapeutic platform for ophthalmic indications. PolyCol’s unique method of action results in accelerated healing and recovery in various ophthalmic disease states and offers a new way to address indications such as dry eye disease, dry age related macular degeneration, and glaucoma. PolyCol is based on patented research from a major U.S. university, combined with additional intellectual property acquired by Stuart Therapeutics. The company has developed applications for PolyCol in treating certain ophthalmic, gastrointestinal, inflammatory, and oncology conditions.
LÜM is a social media, music discovery, and streaming application that allows fans to directly support their favorite emerging artists. The company's application focuses on up and coming artists around the world and provides the ability for users to discover, share, and circulate music. They seek to decrease the disparity in exposure between corporate music and new music, and link-local areas into the undiscovered music that is all around them. By rethinking the interaction between social media and streaming, LÜM will eventually become a live entertainment “talent pool” for up and coming music around the world.

Pyran

Seed Round in 2021
Pyran LLC develops a starting compound for manufacturing paints and plastic chemicals. The company develops a diol product from renewable wood and crop waste resources which is used as a raw material for manufacturing digital versatile discs, paints, bottles, coatings, plastics, ropes, glues, and adhesives. It serves chemical industries. The company was founded in 2017 and is based in Madison, Wisconsin.

OnLume

Series A in 2021
Founded in Madison, WI in 2015, OnLume is providing intuitive and ergonomic solutions for the integration of precise fluorescence image-guided surgery. The company is committed to providing surgeons with the possible images obtained in a well-lit surgical environment in veterinary and human medicine. Prototypes are being tested at their partners, the Laboratory for Optical and Computational Imaging (LOCI) at the University of Wisconsin and the Morgridge Institute for Research in Madison WI. The systems have not been cleared to market by the FDA and are not for sale.

Immuto Scientific

Seed Round in 2021
Immuto Scientific is a biotechnology services company that provides analytical insights to pharmaceutical companies for drug discovery.

SimpleMachines, Inc.

Seed Round in 2017
SimpleMachines, Inc. designs and develops semiconductor chips. The company was incorporated in 2016 and is headquartered in Madison, Wisconsin.

Isomark, LLC

Funding Round in 2017
Isomark, LLC develops a non-invasive breath monitoring technology that allows healthcare providers to detect life-threatening infections. It offers Canary, a breath analyzer to monitor personal health and disease states by measuring and analyzing isotopic biomarkers through exhaled CO2 samples. The company was founded in 2005 and is based in Madison, Wisconsin.

Isomark, LLC

Venture Round in 2014
Isomark, LLC develops a non-invasive breath monitoring technology that allows healthcare providers to detect life-threatening infections. It offers Canary, a breath analyzer to monitor personal health and disease states by measuring and analyzing isotopic biomarkers through exhaled CO2 samples. The company was founded in 2005 and is based in Madison, Wisconsin.

Isomark, LLC

Funding Round in 2016
Isomark, LLC develops a non-invasive breath monitoring technology that allows healthcare providers to detect life-threatening infections. It offers Canary, a breath analyzer to monitor personal health and disease states by measuring and analyzing isotopic biomarkers through exhaled CO2 samples. The company was founded in 2005 and is based in Madison, Wisconsin.

Isomark, LLC

Venture Round in 2016
Isomark, LLC develops a non-invasive breath monitoring technology that allows healthcare providers to detect life-threatening infections. It offers Canary, a breath analyzer to monitor personal health and disease states by measuring and analyzing isotopic biomarkers through exhaled CO2 samples. The company was founded in 2005 and is based in Madison, Wisconsin.

Roche NimbleGen

Series D in 2003
Roche NimbleGen provides products and services to the life science research market. The company offers SeqCap EZ system, a solution-based capture system that enables enrichment of exome in a single test tube; SeqCap EZ library that covers exome designs, gene panels, and custom content designs; and SeqCap EZ reagents to maximize workflow and order different reagent needs. It also provides SeqCap Epi, an enrichment system that includes a set of target enrichment tools for DNA methylation assessment at single-base resolution, as well as offers SeqCap Epi kits and reagents. The company provides a set of preparation and adapter kits for library construction including SignalMap, a software product for browsing of genomic tracks; and NimbleDesign, an online tool that enables users to design SeqCap EZ choice libraries. It offers DNA microarray products and services for CGH, ChIP-chip, DNA methylation, AccuSNP, CGS, instruments, sequence capture arrays, gene expression microarrays, and their associated workflows. The company also provides online technical and instruction support services. Roche NimbleGen was founded in 1999 and is headquartered in Madison, Wisconsin. As of August 8, 2007, Roche NimbleGen operates as a subsidiary of Roche Holding AG.

NeuWave Medical

Series B in 2012
NeuWave Medical develops tools that deliver energy to the human body to treat a variety of serious medical conditions. Their company founders are both engineers and physician-scientists which allows determining a clinical need and design solutions that are clinically relevant, effective, and minimally invasive. They strive to make the highest quality devices that are the products of choice for leading physicians and medical centers around the world. The company was founded in 2004 and is headquartered in Madison, Wisconsin.
Deltanoid Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the research, development, and commercialization of therapies for the treatment of renal diseases, osteoporosis, skin diseases, and other targets. It focuses on vitamin D analogs and other compounds to develop selected therapies through early phases of the drug development process. The company’s product includes DP001 for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease receiving hemodialysis. It also develops DP006 for the treatment of acne. The company was founded in 1999 and is based in Madison, Wisconsin.

HealthMyne, Inc.

Venture Round in 2016
HealthMyne, Inc., a healthcare informatics company, provides novel search, analytics, and imaging solutions to healthcare enterprises. It focuses on providing solutions to cancer care providers. The company’s smart imaging solutions deliver clinical decision support and quality assurance services to reduce diagnostic errors and increase clinical collaboration. Its technology provides physicians with tumor image manipulation, and EHR and image repository search capabilities for diagnosing and treating similar cases. HealthMyne, Inc. was founded in 2013 and is based in Madison, Wisconsin.

HealthMyne, Inc.

Series B in 2018
HealthMyne, Inc., a healthcare informatics company, provides novel search, analytics, and imaging solutions to healthcare enterprises. It focuses on providing solutions to cancer care providers. The company’s smart imaging solutions deliver clinical decision support and quality assurance services to reduce diagnostic errors and increase clinical collaboration. Its technology provides physicians with tumor image manipulation, and EHR and image repository search capabilities for diagnosing and treating similar cases. HealthMyne, Inc. was founded in 2013 and is based in Madison, Wisconsin.

FluGen, Inc.

Series A in 2015
FluGen, Inc. develops vaccines that prevents from the diseases caused by influenza viruses. It offers RedeeFlu, a nasal spray vaccine used to protect against influenza and vaccine-loaded intradermal microneedle delivery device. The company was founded in 2007 and is based in Madison, Wisconsin.

FluGen, Inc.

Series A in 2017
FluGen, Inc. develops vaccines that prevents from the diseases caused by influenza viruses. It offers RedeeFlu, a nasal spray vaccine used to protect against influenza and vaccine-loaded intradermal microneedle delivery device. The company was founded in 2007 and is based in Madison, Wisconsin.

SimpleMachines, Inc.

Series A in 2018
SimpleMachines, Inc. designs and develops semiconductor chips. The company was incorporated in 2016 and is headquartered in Madison, Wisconsin.

PROMISS Diagnostics

Debt Financing in 2020
At PROMISS Diagnostics they take applied science seriously. We believe marrying basic science with cutting-edge analytics can unleash exponential diagnostic potential from otherwise common blood tests. Their team is passionate about driving change and helping more people find hope by developing innovative diagnostic tools that are efficacious, inexpensive, and accessible to all.